Handan Kekeç

Handan Kekeç

Auto-generated profile, based on publicly available information

Handan Kekeç

Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2025 in Respiratory Medicine
Verified
Journal Article
Closed access
HKHandan Kekeç
Handan Kekeç
AAAyse Tana Aslan
Ayse Tana Aslan
AAAyşe Tana Aslan
Ayşe Tana Aslan
ZHZeynep İlkşen Hocoğlu
Zeynep İlkşen Hocoğlu
EYEbru Yalçın
Ebru Yalçın
DDDeniz Doğru
Deniz Doğru

4 August 2025 in Thoracic Research and Practice
Verified
Journal Article
Open access
DTDilber Ademhan Tural
Dilber Ademhan Tural
AAAyse Tana Aslan
Ayse Tana Aslan
GCGüzin Cinel
Güzin Cinel
ECErkan Cakir
Erkan Cakir
SPSevgi Pekcan
Sevgi Pekcan
DDDeniz Doğru
Deniz Doğru
The Cystic Fibrosis Registry of Türkiye (CFRT) was established by the Turkish Pediatric Respiratory Diseases and Cystic Fibrosis Society and has provided detailed information on demographic, clinical, genetic, and treatment-related aspects of cystic fibrosis (CF) patients since 2017. We aimed to describe the current status of CF in Türkiye using CFRT's 2023 annual data. Demographic, clinical, and treatment data were taken from CFRT's 2023 record. In 2023, 2,258 patients from 34 centers were recorded. The median age of patients was 9.1 years, and 46.9% were female, with a median age at diagnosis of 0.3 years. Only 14.9% of the patients were older than 18 years. Genetic analyses were completed in 97.3% of patients. The most common variant, F508del, had a total variant frequency of 22.1%. The median percent predicted FEV1 and FVC were 88.0 and 94.0 in those aged 6-17 years 71.0 and 84.0 in those aged ≥18 years, respectively. The median values of body mass index z-scores were -0.5, and -0.5 for patients 2-18 and older than 18 years, respectively. Chronic colonization with Pseudomonas aeruginosa was present in 17.2% of the patients. Most patients used inhaled recombinant human DNase (87.1%) and oral pancreatic enzyme replacement treatment (83.0%). CF transmembrane conductance regulator (CFTR) modulators were used by 15.9% of patients. Over the year, 24 patients died, with a median age at death of 13.3 years. The CFRT report provides a valuable resource showing the clinical and laboratory data of patients with CF in the country.

20 August 2025 in Balkan Medical Journal
Verified
Journal Article
Open access
HKHandan Kekeç
Handan Kekeç
AAAyse Tana Aslan
Ayse Tana Aslan
AAAyse Tana Aslan
Ayse Tana Aslan
YDYasemin Duman
Yasemin Duman
VMVolkan Medeni
Volkan Medeni
ÖBÖznur Leman Boyunağa
Öznur Leman Boyunağa
Childhood bronchiectasis (BE) is a chronic lung condition that remains under recognized, marked by irreversible widening of the bronchi, frequent respiratory infections, a persistent wet cough, and progressive lung damage, often leading to significant health burdens. Evaluate children with cystic fibrosis (CF) and non-CF BE and to examine the association between clinical presentation and radiological severity of BE using the Bhalla scoring system. Retrospective, single-center observational study. Children aged 0-18 years with a CT-confirmed diagnosis of BE were enrolled. Data on demographics, clinical characteristics, and imaging results were collected retrospectively from medical records. The Bhalla score was used to assess BE severity. Patients were categorized into CF-related and non-CF BE groups. The two groups were compared with respect to clinical features, growth z-scores, hospitalization frequency, and pulmonary function test outcomes. A total of 157 patients were analyzed. Among them, CF accounted for 23.6% of cases, and while the leading causes in the non-CF group were post-infectious BE (28%), immunodeficiency (19.8%), and primary ciliary dyskinesia (12.8%). The CF group presented at an earlier age, had a longer follow-up period, and experienced more frequent hospitalizations (p < 0.001). In the CF group, weight, height, and body mass index z-scores significantly improved from the initial to the final assessment (p = 0.010, p = 0.006, and p = 0.026, respectively), whereas no such improvement was observed in the non-CF group. Severe Bhalla scores were more frequently observed in the CF group (p < 0.001). Among CF patients, Bhalla scores showed a strong correlation with forced expiratory volume in one second (FEV1) in univariate analysis (r = 0.846, p < 0.001), though this was not significant in multivariable analysis (p = 0.434). In the non-CF group, there was no correlation between Bhalla scores and final FEV1 values (p = 0.148, r = 0.212). The results underscore distinct clinical trajectories between CF and non-CF BE in children. Improvements in CF patients suggest the effectiveness of structured clinical management, whereas inconsistent outcomes in non-CF patients point to the need for standardized follow-up protocols. While the Bhalla score may indicate the extent of structural lung disease in CF, it does not independently predict lung function, and therefore should be used as a supplementary, not solitary, measure of disease severity.

24 February 2026 in Chest
Verified
Journal Article
Closed access
HKHandan Kekec
Handan Kekec
AAAyse Tana Aslan
Ayse Tana Aslan
IAIsmail Akdulum
Ismail Akdulum
TETugba Sismanlar Eyuboglu
Tugba Sismanlar Eyuboglu
OUOzge Ulgen
Ozge Ulgen
NKNural Kiper
Nural Kiper

30 June 2025 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
HKHandan Kekeç
Handan Kekeç
AAAbdullah Arpaci
Abdullah Arpaci
ÇEÇiğdem El
Çiğdem El
Purpose: Familial Mediterranean Fever (FMF) (OMIM #249100) exhibits varying clinical severity, influenced by genetic mutations. This study aimed to assess the relationship between FMF genotypes and disease severity in pediatric patients. Materials and Methods: This retrospective cross-sectional study included FMF patients aged 0-18 years who were followed up between January 1, 2016, and June 1, 2017. Demographic data, clinical findings, Pras disease severity scores (Pras score), and MEFV gene mutations were analyzed. Patients were classified into four genetic groups: homozygous, heterozygous, compound heterozygous, and those without detected mutations. Clinical characteristics and disease severity were compared. Results: Among 126 FMF patients (49.2% female), the median age at symptom onset was 60 (12–168) months, and the median age at diagnosis was 76 (23–180) months, resulting in a median diagnostic delay of 12 (0–120) months. Common symptoms included abdominal pain (98%), fever (87.3%), arthralgia (60.3%), and myalgia (60.3%). The median Pras score was 6 (range: 4–11), with 40.5% classified as mild, 43.7% as moderate, and 15.8% as severe. Genetic analysis revealed that 50% of the individuals had compound heterozygous mutations, 30.2% had homozygous mutations, 13.5% had heterozygous mutations, and 6.3% had no mutations. No significant differences were found among mutation groups regarding clinical characteristics or disease severity. Conclusion: Pediatric FMF exhibits clinical heterogeneity, and genotype alone may not be an effective predictor of severity. A comprehensive clinical approach remains essential for diagnosis and management.

30 April 2026 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
HKHandan Kekeç
Handan Kekeç
AAAyse Tana Aslan
Ayse Tana Aslan
AÇAli Buğra Çetinkaya
Ali Buğra Çetinkaya
NKNilgün Kula
Nilgün Kula
FBFATMA BOZDAĞ
FATMA BOZDAĞ
AAAyşe Tana Aslan
Ayşe Tana Aslan
Introduction. Nasal polyps (NP) are benign inflammatory growths originating from the nasal/paranasal sinus mucosa. NPs can occur independently or signify underlying respiratory conditions. This study aimed to evaluate the demographic and clinical characteristics of NPs in children at a pediatric pulmonology department. Method. This cross-sectional study included children aged 0-18 years diagnosed with NP at the pediatric pulmonology department from 2007 to 2025. Patients were categorized into four groups: cystic fibrosis (CF), primary ciliary dyskinesia (PCD), asthma/allergic rhinitis (AR), and undefined etiology. Demographic and clinical data were compared across these groups. Results. A total of 47 (40.4% female) patients were included in the study. The median age of NP diagnosis was 11 years (4.6-17.8). The most common presenting symptoms were nasal obstruction (47, 100%) and mouth breathing during sleep (37, 78.7%). The etiological causes of NPs were PCD (13, 27.7%), CF (9, 19.1%), asthma/AR (11, 23.4%), and an undefined etiology (14, 29.8%). Bilateral NPs were present in 32 (68.1%) cases. In 27 (57.4%) patients, NP was the first presentation, with no other symptoms. Among all PCD patients, NP was the first presentation in 7 (53.8%) of cases. NP recurrence was documented in 14 patients (29.8%). No significant differences were observed among the groups in sex, growth z-scores, or age at NP diagnosis (p>0.05). Bilateral NPs were more common in the PCD group (92.3%) than in the CF (66.7%), asthma/AR (36.3%), and undefined groups (71.4%) (p=0.034). NP recurrence was more frequent in the CF group (66.7%) compared with the PCD (38.5%) and undefined groups (13.6%), while no recurrence was observed in the asthma/AR group (p=0.021). Conclusion. This study highlights the heterogeneity of pediatric NP in causes, presentation, and course. Patients with PCD often present bilaterally, while CF patients have the highest recurrence rate. In PCD, NP was the initial sign in over half of cases, suggesting isolated NP should prompt suspicion of PCD.